{"entity":{"type":"insider","cik":"0001753763","url":"/insider/0001753763","json_url":"/insider/0001753763.json","name":"Scott John K Jr.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2019-03-25","last":"2022-05-03","span_basis":"filed_date"},"name_variants":[{"name":"Scott John K Jr.","source":"filing","n_filings":6,"first_seen":"2019-03-25","last_seen":"2022-05-03"}],"transactions":[{"id":6967978,"accession":"0001437749-22-010726","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-22-010726","line_url":"/filing/0001437749-22-010726#line-1","is_derivative":false,"issuer_cik":"0000810509","issuer_name":"NAVIDEA BIOPHARMACEUTICALS, INC.","issuer_ticker":"NAVB","issuer_name_source":null,"issuer_url":"/issuer/0000810509","owner_cik":"0001753763","owner_name":"Scott John K Jr.","owner_display_name":"Scott John K Jr.","owner_url":"/insider/0001753763","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Series G Redeemable Preferred Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3260.0,"shares_display":"3,260","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":3260.0,"shares_owned_after_display":"3,260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-10","filed_date":"2022-05-03","scope":"insider"},{"id":3164876,"accession":"0001753763-20-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001753763-20-000002","line_url":"/filing/0001753763-20-000002#line-1","is_derivative":false,"issuer_cik":"0000810509","issuer_name":"NAVIDEA BIOPHARMACEUTICALS, INC.","issuer_ticker":"NAVB","issuer_name_source":null,"issuer_url":"/issuer/0000810509","owner_cik":"0001753763","owner_name":"Scott John K Jr.","owner_display_name":"Scott John K Jr.","owner_url":"/insider/0001753763","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":25000.0,"total_display":"25,000.00","total_whole":"25,000","shares_owned_after":8047162.0,"shares_owned_after_display":"8,047,162","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-30","filed_date":"2020-09-02","scope":"insider"},{"id":2442577,"accession":"0001753763-20-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001753763-20-000001","line_url":"/filing/0001753763-20-000001#line-1","is_derivative":false,"issuer_cik":"0000810509","issuer_name":"NAVIDEA BIOPHARMACEUTICALS, INC.","issuer_ticker":"NAVB","issuer_name_source":null,"issuer_url":"/issuer/0000810509","owner_cik":"0001753763","owner_name":"Scott John K Jr.","owner_display_name":"Scott John K Jr.","owner_url":"/insider/0001753763","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2373529.0,"shares_display":"2,373,529","price_per_share":0.85,"price_display":"0.85","price_state":"stated","total_value":2017499.65,"total_display":"2,017,499.65","total_whole":"2,017,500","shares_owned_after":8042162.0,"shares_owned_after_display":"8,042,162","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-13","filed_date":"2020-02-19","scope":"insider"},{"id":7834312,"accession":"0001753763-19-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001753763-19-000003","line_url":"/filing/0001753763-19-000003#line-1","is_derivative":false,"issuer_cik":"0000810509","issuer_name":"NAVIDEA BIOPHARMACEUTICALS, INC.","issuer_ticker":"NAVB","issuer_name_source":null,"issuer_url":"/issuer/0000810509","owner_cik":"0001753763","owner_name":"Scott John K Jr.","owner_display_name":"Scott John K Jr.","owner_url":"/insider/0001753763","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":555555.0,"shares_display":"555,555","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":499999.5,"total_display":"499,999.50","total_whole":"500,000","shares_owned_after":5668633.0,"shares_owned_after_display":"5,668,633","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-06","filed_date":"2019-12-11","scope":"insider"},{"id":8745795,"accession":"0001753763-19-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001753763-19-000002","line_url":"/filing/0001753763-19-000002#line-1","is_derivative":false,"issuer_cik":"0000810509","issuer_name":"NAVIDEA BIOPHARMACEUTICALS, INC.","issuer_ticker":"NAVB","issuer_name_source":null,"issuer_url":"/issuer/0000810509","owner_cik":"0001753763","owner_name":"Scott John K Jr.","owner_display_name":"Scott John K Jr.","owner_url":"/insider/0001753763","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000000.0,"shares_display":"4,000,000","price_per_share":0.75,"price_display":"0.75","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":5113078.0,"shares_owned_after_display":"5,113,078","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-18","filed_date":"2019-06-21","scope":"insider"},{"id":8745792,"accession":"0001753763-19-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001753763-19-000001","line_url":"/filing/0001753763-19-000001#line-1","is_derivative":false,"issuer_cik":"0000810509","issuer_name":"NAVIDEA BIOPHARMACEUTICALS, INC.","issuer_ticker":"NAVB","issuer_name_source":null,"issuer_url":"/issuer/0000810509","owner_cik":"0001753763","owner_name":"Scott John K Jr.","owner_display_name":"Scott John K Jr.","owner_url":"/insider/0001753763","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":357143.0,"shares_display":"357,143","price_per_share":0.14,"price_display":"0.14","price_state":"stated","total_value":50000.02,"total_display":"50,000.02","total_whole":"50,000","shares_owned_after":22261565.0,"shares_owned_after_display":"22,261,565","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-22","filed_date":"2019-03-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000810509","name":"NAVIDEA BIOPHARMACEUTICALS, INC.","url":"/issuer/0000810509","role":"Director, Ten percent owner","n_filings":6,"first_seen":"2019-03-25","last_seen":"2022-05-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001753763","retrieved_at":"2026-08-23T21:38:50+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}